Aquarius Daily Health Horoscope Today, July 01, 2025: Be more loyal to your growth than comfort
You are meant for something bigger, but you must choose it over laziness or fear. Growth may feel uncomfortable, but it brings magic.
Aquarius Health Horoscope
Today
Health-wise, small lifestyle changes will bring big improvement. Your energy may feel low if you're stuck in the same habits. Try a new morning routine, eat fresh fruits, or add 15 minutes of light movement. Your body needs activity and fresh air today. Don't stick to what's convenient – choose what brings long-term health.
Being active supports your mind as well.
Aquarius
Wellness
Horoscope Today
Wellness depends on how much you allow yourself to evolve. You may feel emotional resistance, but deep down, you know you want better. Meditate, change a habit, or say no where needed. Even a small shift in thought can lift your spirit. Staying stuck will feel heavier than moving forward today. Choose change, even if it's slow. You deserve to evolve with ease.
Aquarius Love Horoscope Today
Love energy today favours openness and new patterns.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Trade Bitcoin & Ethereum – No Wallet Needed!
IC Markets
Start Now
Undo
If you're in a relationship, grow together instead of repeating old habits. Try a new way of spending time or resolving things. If single, say yes to something different – maybe a new kind of person or situation. Comfort in love is nice, but growth creates deeper bonding. Speak with honesty and listen deeply.
Aquarius Career Horoscope Today
At work, a new opportunity or idea may appear, but it may look uncomfortable at first. Don't ignore it. This could be a step toward the bigger goal you've been dreaming about.
You may need to leave an old method to embrace something smarter. Your mind is ready for this – give it a chance. Bold choices bring career success.
Aquarius Money Horoscope Today
Financially, today supports growth-oriented decisions. Think long term. It's a good time to invest in learning or a side project. Don't fear a little risk if it leads to new gain. Even if it feels uncertain, your future self will thank you. Abundance follows when you step out of financial habits that no longer serve you.
Aquarius Affirmation Today:
I choose growth, even when it's uncomfortable.
Discover everything about
astrology
at the
Times of India
, including
daily horoscopes
for
Aries
,
Taurus
,
Gemini
,
Cancer
,
Leo
,
Virgo
,
Libra
,
Scorpio
,
Sagittarius
,
Capricorn
,
Aquarius
, and
Pisces
.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Aquarius Daily Health Horoscope Today, July 02, 2025: Everything doesn't need to be fixed
Today, allow yourself to simply feel without needing to fix every detail. Your heart may hold emotions that don't need solutions—just space. Let yourself experience today without judgement. There is power in observing, in being with your emotions rather than rushing to change them. The stars advise you to trust that clarity will come, but first, feel fully. That is where real freedom and healing begin. Aquarius Health Horoscope Today Health today responds well to emotional release. You might be holding tension from overthinking or trying too hard. Let go. Cry if you need, laugh if you feel like it. Your body needs your feelings to flow. Avoid holding everything inside. Gentle stretches, warm baths, and peaceful rest will support your body's balance. Honour your heart and your health will follow naturally. Aquarius Wellness Horoscope Today Your wellness blooms today when you stop over-managing your emotions. Let things come and go without force. You may not understand everything yet, and that's okay. You don't need instant answers. Trust that by sitting with your feelings—without judgement—you are already healing. Be your own safe space. Light music or writing can help you connect gently with your truth. Aquarius Love Horoscope Today In love, don't try to control the rhythm. Let love breathe today. If you're in a relationship, allow space for both joy and silence. If you're single, don't rush into deciding or defining. Just feel—what do you want? What feels right? The answers will come later. Right now, just be open-hearted and honest. Let love meet you where you are emotionally. Aquarius Career Horoscope Today Career-wise, not every problem needs an urgent fix. Some things just need time. Try to observe rather than react. Your ability to see from a higher perspective helps you stand out. A quiet idea may rise today—don't ignore it. Give your creativity freedom without pushing it too hard. Let the work unfold naturally with ease and trust. Aquarius Money Horoscope Today Financially, trust your instincts. If something doesn't feel right, wait. But don't over-analyse. A calm review of your finances today can reveal areas of ease. You may also get an unexpected suggestion or offer. Listen, feel, then decide. Wealth grows when it's aligned with emotional clarity, not just numbers. Let your heart and head both guide the way. Aquarius Affirmation Today: I allow myself to feel fully without rushing change. Discover everything about astrology at the Times of India , including daily horoscopes for Aries , Taurus , Gemini , Cancer , Leo , Virgo , Libra , Scorpio , Sagittarius , Capricorn , Aquarius , and Pisces .
Time of India
an hour ago
- Time of India
Russia-Ukraine war: Donald Trump pauses key weapons shipments to Kyiv; says 'decision made to put America's interests first'
US President Donald Trump - File Image The US on Tuesday announced that it would suspend certain crucial arms deliveries to Ukraine, previously pledged under President Biden's administration, potentially impacting Kyiv's defence against Russian aggression. "This decision was made to put America's interests first following a DOD (department of defense) review of our nation's military support and assistance to other countries across the globe," White House deputy press secretary Anna Kelly said in a statement, AFP reported. The Biden administration's previous commitments of munitions to Ukraine have been paused under President Donald Trump's leadership, following defence department assessments of US stockpiles and shifting priorities. This follows Trump's recent directive for US missile strikes on Iranian nuclear facilities. A US official, speaking anonymously, revealed that Pentagon reviews found insufficient stocks of certain promised weapons, leading to the cancellation of some planned deliveries. The specific weapons affected remain undisclosed. Spokesman Sean Parnell emphasised US military readiness, noting that pending legislation would enhance defence capabilities against contemporary threats. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo This suspension of US weapons support impacts Ukraine during intensified Russian aerial attacks, complicating Trump-backed peace initiatives. Diplomatic discussions have ceased. The US has delivered over $66 billion in military support to Ukraine since Russia's February 2022 invasion. At the Nato summit, Trump discussed potential Patriot air defence missile system deliveries with President Zelenskyy, acknowledging their effectiveness: "They do want to have the antimissile missiles, OK, as they call them, the Patriots," Trump said then. "And we're going to see if we can make some available. We need them, too. We're supplying them to Israel, and they're very effective, 100% effective. Hard to believe how effective. They do want that more than any other thing.
Time of India
an hour ago
- Time of India
Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S's Ozempic and Wegovy in key markets as it races to be among the first few to reap a windfall after patents on the blockbuster weight-loss drugs expire next year. The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some emerging markets, its managing director, Siddharth Mittal, told Bloomberg News. 'I would say that we have the best chance in Canada' to start launching off-patent semaglutide, he said. 'If everything goes seamlessly,' then Biocon can receive an approval to sell sometime in 2026, Mittal added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List The Kiran Mazumdar Shaw-led insulin maker is joining the leagues of the world's largest generic drugmakers, which includes Sandoz Group AG, in eyeing the weight-loss drug market in Canada, where Novo is set to lose patent protection on semaglutide early next year. The Danish drugmaker, which says it controls about 70% of the global market for these drugs, will forfeit exclusive rights in many other markets from 2026, with patents in India expiring around April of next year. That patent expiration does not include the US, Europe or Japan. Live Events Other firms, including sector giant Teva Pharmaceutical Industries Ltd. and China's Gan & Lee Pharmaceutical Ltd., are gearing up likewise for a slice of the fast-growing global market for generic obesity medicines. But the Indian firm aims to be the first to launch a semaglutide copycat drug in Canada. 'I don't expect many companies to have crossed the finish line by next year,' Mittal said. The drugmaker also is looking to sell GLP-1 therapies in Latin American countries such as Brazil and Mexico, along with Asia-Pacific markets like Malaysia, Hong Kong, Australia, New Zealand and in its home base of India. 'We definitely see emerging markets where there is still under-penetration,' Mittal said. 'There's a huge scope for market expansion.' Biocon was the first generic drugmaker to receive approval to sell the generic version of liraglutide — Novo's older weight loss and diabetes drug, sold as Victoza and Saxenda — in the UK last year. India Launch Novo launched Wegovy in India last month, following Eli Lilly & Co.'s Mounjaro entry, as those Western drugmakers seek to tap the country with the world's third-largest obese population. Eli Lilly's Mounjaro has a longer runway with patent protection, which doesn't expire until at least 2030 in most countries. Biocon will start phase-3 trials for semaglutide in India 'soon,' and plans to file for approval by the end of next year, Mittal said. Rivals such as Cipla Ltd. and Torrent Pharmaceuticals Ltd. also are in the race to develop and market off-patent versions of Novo's drug in India, which has at least 100 million obese people. 'Crowded Market' 'It will be a crowded market,' Mittal said, adding that Biocon is relying on its expertise in making insulin to retain an edge over local peers. The company doesn't expect significant price erosion for Wegovy copies in India since the price point at which Novo launched 'is quite reasonable,' he said. The average price may slip by about a fifth, Mittal estimated, compared with the roughly 90% price erosion typically seen for blockbuster drugs after generic firms rush in.
